Primary Occurrence of Cardiovascular Events After Adding Sodium–Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes-Reference-Cited by-同舟云学术

Primary Occurrence of Cardiovascular Events After Adding Sodium–Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes

Published:2023-06 Issue:6 Volume:176 Page:751-760
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Richardson Tadarro L.¹^ORCID,Halvorson Alese E.²^ORCID,Hackstadt Amber J.²,Hung Adriana M.¹^ORCID,Greevy Robert²^ORCID,Grijalva Carlos G.³,Elasy Tom A.¹^ORCID,Roumie Christianne L.⁴^ORCID

Affiliation:

1. VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee (T.L.R., A.M.H., T.A.E.)

2. VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee (A.E.H., A.J.H., R.G.)

3. VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee (C.G.G.)

4. VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); and Departments of Medicine and Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee (C.L.R.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference56 articles.

1. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study

2. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

3. Diabetes and Cardiovascular Disease

4. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes;Journal of the American College of Cardiology;2024-09

2. Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and cerebrovascular diseases: a meta-analysis of controlled clinical trials;Frontiers in Endocrinology;2024-08-23

3. Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes;Journal of the American College of Cardiology;2024-08

4. Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes;BMJ Open Diabetes Research & Care;2024-05

5. Type 2 diabetes patients requiring empagliflozin in Southeast of Iran: Frequency and guideline adherence (2022–2023);Hipertensión y Riesgo Vascular;2024-04